2020 Annual Course eBundle (all four Annual Course eModules for the price of three, denoted with an *asterisk)
| - Members: $149
- Non-members: $209
|
Anti-Seizure Medications and Pharmacology Pearls | 1.0 AMA PRA Category 1 Credit™ | $19 for members, $29 for non-members
This novice-level e-module focuses on grouping currently available anti-seizure medications by mechanism of action. Clinical pearls for each anti-seizure medication are given to inform medication choice targeted toward reducing drug interactions, management of comorbid conditions, and reducing side effects.
Catamenial Epilepsy Treatment | 1.0 AMA PRA Category 1 Credit™ | $19 for members, $29 for non-members
This new interactive e-module introduces learners to the physiological concepts and seizure patterns indicative of Catamenial Epilepsy (CE). Participants learn how to identify the most common presentations of CE as well as hormonal and non-hormonal treatment approaches for CE.
Weaning Antiseizure Medications | 1.0 AMA PRA Category 1 Credit™ | $19 for members, $29 for non-members
Starting with a review of the American Academy of Neurology 2021 Practice Advisory, this self-paced, interactive course offers a practical framework for if, when, and how to wean patients off antiseizure medications. Participants are guided through realistic patient scenarios that demonstrate how to use patient data and current research to determine patient readiness for medication withdrawal.
Neurocognitive Disabilities: A Best Practice Overview of Care (content sourced from the AES2020 Best Practices Symposium) | 2.5 AMA PRA Category 1 Credits™ | $49 for members, $69 for non-members
Focuses on care information for patients with neurocognitive and disabilities. Case study examples will include Autism Spectrum Disorder, Angelman Syndrome, and Dravet Syndrome.
*Diagnosis of New Onset Epilepsy (content sourced from the AES2020 Annual Course) 1.5 AMA PRA Category 1 Credits™| $49 for members, $69 for non-members
Explores current advances in the diagnosis
of new-onset epilepsy.
*Treatment of New Onset Epilepsy (content sourced from the AES2020 Annual Course) 1.5 AMA PRA Category 1 Credits™| $49 for members, $69 for non-members
Explores current advances in the treatment
of new-onset epilepsy. Experts will cover treatment of new onset epilepsy and address genetic testing and psychogenic non-epileptic seizures (PNES).
*Diagnosis of Drug Resistant Epilepsy (content sourced from the AES2020 Annual Course) 1.5 AMA PRA Category 1 Credits™| $49 for members, $69 for non-members
Explores current advances in the
diagnosis of drug-resistant epilepsies. Experts will cover treatment and diagnostic issues related to drug-resistant epilepsy such as gene therapy, wearables, and autoimmune evaluation.
*Treatment of Drug Resistant Epilepsy (content sourced from the AES2020 Annual Course) 1.5 AMA PRA Category 1 Credits™| $49 for members, $69 for non-members
Explores current advances in the
treatment of drug-resistant epilepsy. Experts will cover treatment of drug-resistant epilepsy including surgery in older adults, new anti-seizure medications, and psychiatric and cognitive outcomes of epilepsy surgery.
*The American Epilepsy Society designates these enduring activities for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AKH Inc., Advancing Knowledge in Healthcare designates these education activities for a maximum of 8.50 contact hours.